Solvay Generates Strong Free Cash Flow in 2025 Despite a Deteriorated Market Environment
Belgian chemical company Solvay announced its annual results for 2025 on Tuesday, showcasing satisfactory cash flow generation and maintaining a solid EBITDA margin. The company operates in an environment marked by persistent market weakness and geopolitical uncertainty.
Robust Financial Performance Amidst Challenges
Solvay demonstrated strong free cash flow generation during the fiscal year 2025, despite significant headwinds. The group maintained an attractive EBITDA margin throughout the period, despite ongoing economic difficulties. CEO Philippe Kehren emphasized that the group continued its strategic and sustainability commitments while navigating a fragile macroeconomic and geopolitical context. Performance improvements were based on several pillars: cost reduction progress, rigorous capital allocation management, and advancement in energy transition initiatives. However, management acknowledges that certain transformational expenditures weigh on short-term results, including exiting the Transition Services Agreement, rolling out the new ERP, and restructuring Fluorine operations. These transformation investments are described as essential for the group’s medium and long-term development.
Cost Savings and Industrial Footprint Optimization
The cost-saving program generated over 200 million euros in the past two years, particularly through digitalization and organizational simplification. Concurrently, Solvay substantially optimized its industrial footprint. The group initiated a consultation process yesterday regarding the adjustment of the production capacity at Torrelavega, Spain, to 420 kt. In the peroxides sector, closures in Warrington, UK, and Povoa, Portugal were completed. The Special Chem business closed its Salindres site in France and announced the restructuring of its two German sites. Capital allocation remains governed by a strict framework, prioritizing essential investments and dividend payments, while discretionary investments focus on targeted opportunities, notably in electronic grade bicarbonate and peroxides.
Outlook for 2026 and Financial Policy
For 2026, Solvay anticipates the persistence of geopolitical and macroeconomic tensions, which will continue to impact final demand, while competitive price pressure is expected to remain in certain product lines. Transformational expenditures will negatively impact EBITDA and free cash flow before gradually diminishing starting in 2027. The group will also continue optimizing its CO? emissions rights portfolio, with an impact similar to that of 2025. Regarding financial policy, the group reaffirms its commitment to a stable to growing dividend and maintaining an investment-grade rating. The Board of Directors proposes a total gross dividend of 2.43 euros per share, subject to approval at the Annual General Meeting on May 12, 2026. Considering the interim gross dividend of 0.97 euros per share paid on January 21, 2026, a final gross dividend of 1.46 euros per share will be paid on May 20, 2026.
